Skip to main content
Erschienen in:

17.09.2024 | Original Article

Characteristics of cases for which esophageal endoscopic submucosal dissection under general anesthesia is recommended

verfasst von: Atsushi Goto, Koichi Hamabe, Shunsuke Ito, Shinichi Hashimoto, Jun Nishikawa, Taro Takami

Erschienen in: Esophagus | Ausgabe 1/2025

Einloggen, um Zugang zu erhalten

Abstract

Background/aims

Esophageal endoscopic submucosal dissection (ESD) performed under general anesthesia can potentially provide more stable treatment in difficult cases than that under sedation. We evaluated the clinical characteristics and outcomes of ESD performed under general anesthesia compared with those under propofol sedation and discussed the cases in which general anesthesia is recommended.

Patients and methods

In total, 292 lesions in 265 consecutive patients undergoing esophageal ESD at Yamaguchi University Hospital from 2013 to 2023 were included in this retrospective study.

Results

ESD was performed under general anesthesia for 92 lesions in 81 patients and under propofol sedation for 200 lesions in 184 patients. Tumor long-axis diameter was larger (39.8 ± 14.4 mm vs. 32.4 ± 9.9 mm, p < 0.01) and dissection speed was faster (10.5 ± 5.9 mm2/min vs. 7.5 ± 4.2 mm2/min, p < 0.01) in the general anesthesia group versus the sedation group. In the sedation group, a treatment history of pharyngeal cancer was significantly associated with a slower dissection speed (p = 0.037). The sedation group showed higher frequencies of hypoxemia (0% vs 9.8%, p < 0.01), interruption due to body movement (0% vs 13%, p < 0.01), and acute adverse events (21.7% vs 33.5%, p = 0.05). A treatment history of pharyngeal cancer was shown to be the significant factor contributing to acute adverse events (p = 0.018).

Conclusion

Esophageal ESD under general anesthesia can be a treatment option in patients with difficulty in performing stable procedures with propofol sedation. Especially in patients with a treatment history of pharyngeal cancer in whom ESD is more difficult to be performed and who are at higher risk for acute adverse events, general anesthesia can be considered.
Literatur
1.
Zurück zum Zitat Ishihara R, Arima M, Iizuka T, et al. Endoscopic submucosal dissection/endoscopic mucosal resection guidelines for esophageal cancer. Dig Endosc. 2020;32:452–93.CrossRefPubMed Ishihara R, Arima M, Iizuka T, et al. Endoscopic submucosal dissection/endoscopic mucosal resection guidelines for esophageal cancer. Dig Endosc. 2020;32:452–93.CrossRefPubMed
2.
Zurück zum Zitat Ashikari K, Nonaka T, Higurashi T, et al. Efficacy of sedation with dexmedetomidine plus propofol during esophageal endoscopic submucosal dissection. J Gastroenterol Hepatol. 2021;36:1920–6.CrossRefPubMed Ashikari K, Nonaka T, Higurashi T, et al. Efficacy of sedation with dexmedetomidine plus propofol during esophageal endoscopic submucosal dissection. J Gastroenterol Hepatol. 2021;36:1920–6.CrossRefPubMed
3.
Zurück zum Zitat Yamagata T, Hirasawa D, Fujita N, et al. Efficacy of propofol sedation for endoscopic submucosal dissection (ESD): assessment with prospective data collection. Intern Med. 2011;50:1455–60.CrossRefPubMed Yamagata T, Hirasawa D, Fujita N, et al. Efficacy of propofol sedation for endoscopic submucosal dissection (ESD): assessment with prospective data collection. Intern Med. 2011;50:1455–60.CrossRefPubMed
4.
Zurück zum Zitat Obara K, Haruma K, Irisawa A, et al. Guidelines for sedation in gastroenterological endoscopy. Dig Endosc. 2015;27:435–49.CrossRefPubMed Obara K, Haruma K, Irisawa A, et al. Guidelines for sedation in gastroenterological endoscopy. Dig Endosc. 2015;27:435–49.CrossRefPubMed
5.
Zurück zum Zitat Charlson M, Carrozzino D, Guidi J, et al. Charlson Comorbidity Index: a critical review of clinimetric properties. Psychother Psychosom. 2022;91:8–35.CrossRefPubMed Charlson M, Carrozzino D, Guidi J, et al. Charlson Comorbidity Index: a critical review of clinimetric properties. Psychother Psychosom. 2022;91:8–35.CrossRefPubMed
6.
Zurück zum Zitat Hamada K, Kawano K, Yamauchi A, et al. Efficacy of endoscopic submucosal dissection of esophageal neoplasms under general anesthesia. Clin Endosc. 2019;52:252–7.CrossRefPubMedPubMedCentral Hamada K, Kawano K, Yamauchi A, et al. Efficacy of endoscopic submucosal dissection of esophageal neoplasms under general anesthesia. Clin Endosc. 2019;52:252–7.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Fujishiro M, Yahagi N, Kakushima N, et al. Endoscopic submucosal dissection of esophageal squamous cell neoplasms. Clin Gastroenterol Hepatol. 2006;4:688–94.CrossRefPubMed Fujishiro M, Yahagi N, Kakushima N, et al. Endoscopic submucosal dissection of esophageal squamous cell neoplasms. Clin Gastroenterol Hepatol. 2006;4:688–94.CrossRefPubMed
8.
Zurück zum Zitat Koike Y, Hirasawa D, Fujita N, et al. Usefulness of the thread-traction method in esophageal endoscopic submucosal dissection: randomized controlled trial. Dig Endosc. 2015;27:303–9.CrossRefPubMed Koike Y, Hirasawa D, Fujita N, et al. Usefulness of the thread-traction method in esophageal endoscopic submucosal dissection: randomized controlled trial. Dig Endosc. 2015;27:303–9.CrossRefPubMed
9.
Zurück zum Zitat Sigl JC, Chamoun NG. An introduction to bispectral analysis for the electroencephalogram. J Clin Monit. 1994;10:392–404.CrossRefPubMed Sigl JC, Chamoun NG. An introduction to bispectral analysis for the electroencephalogram. J Clin Monit. 1994;10:392–404.CrossRefPubMed
10.
Zurück zum Zitat Imagawa A, Fujiki S, Kawahara Y, et al. Satisfaction with bispectral index monitoring of propofol-mediated sedation during endoscopic submucosal dissection: a prospective, randomized study. Endoscopy. 2008;40:905–9.CrossRefPubMed Imagawa A, Fujiki S, Kawahara Y, et al. Satisfaction with bispectral index monitoring of propofol-mediated sedation during endoscopic submucosal dissection: a prospective, randomized study. Endoscopy. 2008;40:905–9.CrossRefPubMed
11.
Zurück zum Zitat Leung CM, Hui RW. Comparing general anaesthesia versus sedation for endoscopic submucosal dissection: results from a systematic review and meta-analysis. Anaesthesiol Intensive Ther. 2023;55:9–17.CrossRefPubMedPubMedCentral Leung CM, Hui RW. Comparing general anaesthesia versus sedation for endoscopic submucosal dissection: results from a systematic review and meta-analysis. Anaesthesiol Intensive Ther. 2023;55:9–17.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Yurtlu DA, Aslan F, Ayvat P, et al. Propofol-based sedation versus general anesthesia for endoscopic submucosal dissection. Medicine (Baltim). 2016;95: e3680.CrossRef Yurtlu DA, Aslan F, Ayvat P, et al. Propofol-based sedation versus general anesthesia for endoscopic submucosal dissection. Medicine (Baltim). 2016;95: e3680.CrossRef
13.
Zurück zum Zitat Kim SH, Choi YS, Lee SK, et al. Comparison of general anesthesia and conscious sedation in procedure-related complications during esophageal endoscopic submucosal dissection. Surg Endosc. 2020;34:3560–6.CrossRefPubMed Kim SH, Choi YS, Lee SK, et al. Comparison of general anesthesia and conscious sedation in procedure-related complications during esophageal endoscopic submucosal dissection. Surg Endosc. 2020;34:3560–6.CrossRefPubMed
14.
Zurück zum Zitat Mitsui T, Kadota T, Wakabayashi M, et al. Factors of technical difficulty in conventional and traction-assisted esophageal endoscopic submucosal dissection. Esophagus. 2022;19:452–9.CrossRefPubMed Mitsui T, Kadota T, Wakabayashi M, et al. Factors of technical difficulty in conventional and traction-assisted esophageal endoscopic submucosal dissection. Esophagus. 2022;19:452–9.CrossRefPubMed
15.
Zurück zum Zitat Givens DJ, Karnell LH, Gupta AK, et al. Adverse events associated with concurrent chemoradiation therapy in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg. 2009;135:1209–17.CrossRefPubMed Givens DJ, Karnell LH, Gupta AK, et al. Adverse events associated with concurrent chemoradiation therapy in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg. 2009;135:1209–17.CrossRefPubMed
16.
Zurück zum Zitat McBride SM, Parambi RJ, Jang JW, et al. Intensity-modulated versus conventional radiation therapy for oropharyngeal carcinoma: long-term dysphagia and tumor control outcomes. Head Neck. 2014;36:492–8.CrossRefPubMed McBride SM, Parambi RJ, Jang JW, et al. Intensity-modulated versus conventional radiation therapy for oropharyngeal carcinoma: long-term dysphagia and tumor control outcomes. Head Neck. 2014;36:492–8.CrossRefPubMed
17.
Zurück zum Zitat Motz K, Herbert RJ, Fakhry C, et al. Short- and long-term outcomes of oropharyngeal cancer care in the elderly. Laryngoscope. 2018;128:2084–93.CrossRefPubMed Motz K, Herbert RJ, Fakhry C, et al. Short- and long-term outcomes of oropharyngeal cancer care in the elderly. Laryngoscope. 2018;128:2084–93.CrossRefPubMed
18.
Zurück zum Zitat Sanguineti G, Adapala P, Endres EJ, et al. Dosimetric predictors of laryngeal edema. Int J Radiat Oncol Biol Phys. 2007;68:741–9.CrossRefPubMed Sanguineti G, Adapala P, Endres EJ, et al. Dosimetric predictors of laryngeal edema. Int J Radiat Oncol Biol Phys. 2007;68:741–9.CrossRefPubMed
19.
Zurück zum Zitat Windisch W, Karagiannidis C. [Difficult extubation] in German. Med Klin Intensivmed Notfmed. 2012;107:537–42.CrossRefPubMed Windisch W, Karagiannidis C. [Difficult extubation] in German. Med Klin Intensivmed Notfmed. 2012;107:537–42.CrossRefPubMed
20.
Zurück zum Zitat Ono S, Fujishiro M, Niimi K, et al. Long-term outcomes of endoscopic submucosal dissection for superficial esophageal squamous cell neoplasms. Gastrointest Endosc. 2009;70:860–6.CrossRefPubMed Ono S, Fujishiro M, Niimi K, et al. Long-term outcomes of endoscopic submucosal dissection for superficial esophageal squamous cell neoplasms. Gastrointest Endosc. 2009;70:860–6.CrossRefPubMed
21.
Zurück zum Zitat Takahashi H, Arimura Y, Hosokawa M, et al. Endoscopic submucosal dissection is superior to conventional endoscopic resection as a curative treatment for early squamous cell carcinoma of the esophagus (with video). Gastrointest Endosc. 2010;72(255–64):264.e1-2. Takahashi H, Arimura Y, Hosokawa M, et al. Endoscopic submucosal dissection is superior to conventional endoscopic resection as a curative treatment for early squamous cell carcinoma of the esophagus (with video). Gastrointest Endosc. 2010;72(255–64):264.e1-2.
22.
Zurück zum Zitat Triantafillidis JK, Merikas E, Nikolakis D, et al. Sedation in gastrointestinal endoscopy: current issues. World J Gastroenterol. 2013;19:463–81.CrossRefPubMedPubMedCentral Triantafillidis JK, Merikas E, Nikolakis D, et al. Sedation in gastrointestinal endoscopy: current issues. World J Gastroenterol. 2013;19:463–81.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Nonaka T, Inamori M, Miyashita T, et al. Can sedation using a combination of propofol and dexmedetomidine enhance the satisfaction of the endoscopist in endoscopic submucosal dissection? Endosc Int Open. 2018;6:E3-10.CrossRefPubMedPubMedCentral Nonaka T, Inamori M, Miyashita T, et al. Can sedation using a combination of propofol and dexmedetomidine enhance the satisfaction of the endoscopist in endoscopic submucosal dissection? Endosc Int Open. 2018;6:E3-10.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Yoshio T, Ishiyama A, Tsuchida T, et al. Efficacy of novel sedation using the combination of dexmedetomidine and midazolam during endoscopic submucosal dissection for esophageal squamous cell carcinoma. Esophagus. 2019;16:285–91.CrossRefPubMed Yoshio T, Ishiyama A, Tsuchida T, et al. Efficacy of novel sedation using the combination of dexmedetomidine and midazolam during endoscopic submucosal dissection for esophageal squamous cell carcinoma. Esophagus. 2019;16:285–91.CrossRefPubMed
Metadaten
Titel
Characteristics of cases for which esophageal endoscopic submucosal dissection under general anesthesia is recommended
verfasst von
Atsushi Goto
Koichi Hamabe
Shunsuke Ito
Shinichi Hashimoto
Jun Nishikawa
Taro Takami
Publikationsdatum
17.09.2024
Verlag
Springer Nature Singapore
Erschienen in
Esophagus / Ausgabe 1/2025
Print ISSN: 1612-9059
Elektronische ISSN: 1612-9067
DOI
https://doi.org/10.1007/s10388-024-01086-4

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Innere Medizin

Vorhofflimmern: Antikoagulation vor Schlaganfall von Vorteil

Erleiden Menschen mit Vorhofflimmern einen ischämischen Schlaganfall, ist dieser weniger schwer, auch sind Infarktgröße und Blutungsrisiko geringer, wenn sie zuvor orale Antikoagulanzien erhalten haben. Die Art der Antikoagulation spielt dabei keine Rolle.

Frühe CLL-Therapie: BTK-Hemmer verlängert EFS und PFS, aber nicht OS

Auch nach sechs Jahren ergibt sich kein Überlebensvorteil einer Therapie mit dem BTK-Hemmer Ibrutinib für Menschen mit frühem CLL-Stadium und erhöhtem Progressionsrisiko. Die Progressionsrate wird mit der Behandlung jedoch um über 80% gesenkt.

Mehr Cholesterin im Essen = höheres Herzinfarktrisiko

Je mehr Cholesterin man täglich über die Nahrung zu sich nimmt, desto höher ist offenbar das Herzinfarktrisiko – das legt eine Studie mit US-Veteranen zumindest für Männer nahe.

Antikoagulation bei Vorhofflimmern: Sind DOAK noch zu toppen?

Gegen Thromboembolien so wirksam wie ein DOAK, bei zugleich geringerem Blutungsrisiko – werden Faktor-XI-Hemmer als neue Antikoagulanzien dieser Erwartung gerecht? Eine aktuell publizierte Vergleichsstudie gibt darüber Aufschluss.

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.